UCSF Launches Study on Deadly Heart Condition Affecting Athletes

258 A8971 Headshot
Alexandru Acea R Qg Km1h2ag A Unsplash

The University of California San Francisco is conducting a six-month clinical trial on hypertrophic cardiomyopathy, a deadly heart condition that can affect athletes. 

UCSF will use Vivalink's Biometrics Data Platform for the study, which will consist of 70 patients, and will evaluate if regimented moderate intensity exercise improves overall exercise capacity and cardiac blood flow. 

Log in to view the full article
Sponsored
DynaDome Transforms Outdoor Pool Into Year-Round Paradise
DynaDome Retractable Enclosures
DynaDome Transforms Outdoor Pool Into Year-Round Paradise
Page 1 of 273
Next Page
Buyer's Guide
Information on more than 3,000 companies, sorted by category. Listings are updated daily.
Learn More
Buyer's Guide
AB Show 2025 in San Diego
AB Show is a solution-focused event for athletics, fitness, recreation and military professionals.
Nov. 5-8, 2025
Learn More
AB Show 2025